T 0848/10 (BAFF receptor BCMA/BIOGEN IDEC, APOTECH) of 16.10.2014
- European Case Law Identifier
- ECLI:EP:BA:2014:T084810.20141016
- Date of decision
- 16 October 2014
- Case number
- T 0848/10
- Online on
- 24 November 2014
- Petition for review of
- -
- Application number
- 00957502.8
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- BAFF RECEPTOR (BCMA), AN IMMUNOREGULATORY AGENT
- Applicant name
- Biogen Idec MA Inc.
Apotech R&D S.A. - Opponent name
- Amgen Inc.
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 84European Patent Convention Art 83European Patent Convention Art 54European Patent Convention Art 56
- Keywords
- Admissibility: Main request (yes)
Main request - requirements of the EPC met (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent as amended in the following version:
Description: pages 3 - 23 received at the oral proceedings of 16 October 2014
Claims: No. 1 - 11 of the Main Request received at the oral proceedings of 16 October 2014
Figures: No. 1 - 16 of the patent as granted.